THROMBOLYSIS
Clinical trials for THROMBOLYSIS explained in plain language.
Never miss a new study
Get alerted when new THROMBOLYSIS trials appear
Sign up with your email to follow new studies for THROMBOLYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to dissolve dangerous blood clots in the leg
Disease control CompletedThis study tested a drug called BAY 3018250 in 258 people with deep vein thrombosis (DVT), a condition where blood clots form in deep leg veins. The drug is designed to dissolve clots, unlike standard blood thinners that only prevent clots from growing. Researchers compared two d…
Matched conditions: THROMBOLYSIS
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study tests if adding a Clot-Buster before mechanical stroke treatment boosts recovery
Disease control CompletedThis study looked at 391 people with a type of stroke caused by a blockage in a major brain artery, treated 4.5 to 24 hours after symptoms started. Half got a clot-busting drug called tenecteplase followed by a mechanical clot removal procedure, while the other half had the proce…
Matched conditions: THROMBOLYSIS
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC